Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Vitamin E versus propolis as an add-on therapy to sitagliptin/metformin on oxidant/antioxidant status and lipid profile in type 2 diabetic patients

Sarraa Dhiaa, Imad A. Thanoon, Nabeel N. Fadhil

. 2023 ; 92 (1) : 14-21. [pub] 20230303

Jazyk angličtina Země Česko

Typ dokumentu klinická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc23000945

The main health care challenges associated with diabetic patients are glycemic control. Insulin defection has been regarded as the mainstay which needs to be tackled to avoid glucose over presence in the circulatory system. These challenges have always been conjoined with the patient's redox status, hence, oxidants/antioxidants determine the fate of pancreatic tissue status and they are reciprocally interrelated. Various remedies have been utilized by patients themselves and healthcare workers to control hyperglycemia if any. Herbal and pharmacological therapy were always being used hand in hand. Herein, we are demonstrating the antioxidant effect of propolis and its role in modulation of lipid profile in type 2 diabetic patients using vitamin E for comparison in sequential mode i.e. vitamin E used for 8 weeks followed one-week washout period and then propolis therapy started in the same group of patients (n = 45). Thereby a sample of serum has been collected in the first visit (baseline and vitamin E started, followed by collecting serum after 8 weeks (second visit); followed by commencing of propolis after a washout week from the second visit, at the third visit another serum sample collected from all patients. Serum was analyzed for oxidant/antioxidant status represented by malondialdehyde (MDA) and total antioxidant status (TAS). Additionally, lipid profile has been measured from the same samples. The results indicate that both propolis and vitamin E positively modulated the measured parameters with superiority of propolis over vitamin E in improving these measured biomolecules. To conclude, propolis is an overall safe natural product and is inducing such positive effects in the diabetic patient, we do advise these patients to start propolis therapy as an adjuvant medication to control these deleterious biomolecules.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23000945
003      
CZ-PrNML
005      
20230401231527.0
007      
ta
008      
230307s2023 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.31482/mmsl.2022.015 $2 doi
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Dhiaa, Sarraa $u College of Pharmacy, Alhadbaa Street, 41002, University of Mosul, Mosul, Ninevah Province, Iraq
245    10
$a Vitamin E versus propolis as an add-on therapy to sitagliptin/metformin on oxidant/antioxidant status and lipid profile in type 2 diabetic patients / $c Sarraa Dhiaa, Imad A. Thanoon, Nabeel N. Fadhil
520    9_
$a The main health care challenges associated with diabetic patients are glycemic control. Insulin defection has been regarded as the mainstay which needs to be tackled to avoid glucose over presence in the circulatory system. These challenges have always been conjoined with the patient's redox status, hence, oxidants/antioxidants determine the fate of pancreatic tissue status and they are reciprocally interrelated. Various remedies have been utilized by patients themselves and healthcare workers to control hyperglycemia if any. Herbal and pharmacological therapy were always being used hand in hand. Herein, we are demonstrating the antioxidant effect of propolis and its role in modulation of lipid profile in type 2 diabetic patients using vitamin E for comparison in sequential mode i.e. vitamin E used for 8 weeks followed one-week washout period and then propolis therapy started in the same group of patients (n = 45). Thereby a sample of serum has been collected in the first visit (baseline and vitamin E started, followed by collecting serum after 8 weeks (second visit); followed by commencing of propolis after a washout week from the second visit, at the third visit another serum sample collected from all patients. Serum was analyzed for oxidant/antioxidant status represented by malondialdehyde (MDA) and total antioxidant status (TAS). Additionally, lipid profile has been measured from the same samples. The results indicate that both propolis and vitamin E positively modulated the measured parameters with superiority of propolis over vitamin E in improving these measured biomolecules. To conclude, propolis is an overall safe natural product and is inducing such positive effects in the diabetic patient, we do advise these patients to start propolis therapy as an adjuvant medication to control these deleterious biomolecules.
650    _7
$a lidé středního věku $7 D008875 $2 czmesh
650    _7
$a lidé $7 D006801 $2 czmesh
650    17
$a diabetes mellitus 2. typu $x farmakoterapie $x krev $7 D003924 $2 czmesh
650    _7
$a vitamin E $x aplikace a dávkování $x farmakologie $7 D014810 $2 czmesh
650    _7
$a propolis $x aplikace a dávkování $x farmakologie $7 D011429 $2 czmesh
650    _7
$a kombinace léků sitagliptin a metformin $x aplikace a dávkování $7 D000068899 $2 czmesh
650    _7
$a biochemická analýza krve $x metody $x přístrojové vybavení $7 D001774 $2 czmesh
650    _7
$a lipidy $x krev $7 D008055 $2 czmesh
650    _7
$a malondialdehyd $x krev $7 D008315 $2 czmesh
650    _7
$a statistika jako téma $7 D013223 $2 czmesh
650    _7
$a oxidační stres $x účinky léků $7 D018384 $2 czmesh
651    _7
$a Irák $7 D007493 $2 czmesh
655    _7
$a klinická studie $7 D000068397 $2 czmesh
700    1_
$a Thanoon, Imad A. $u College of Medicine, Alhadbaa Street, 41002, University of Mosul, Mosul, Ninevah Province, Iraq
700    1_
$a Fadhil, Nabeel N. $u College of Medicine, Alhadbaa Street, 41002, Ninevah University, Mosul, Ninevah Province, Iraq
773    0_
$t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 92, č. 1 (2023), s. 14-21 $w MED00011116
856    41
$u https://mmsl.cz/artkey/mms-202301-0002_vitamin-e-versus-propolis-as-an-add-on-therapy-to-sitagliptin-metformin-on-oxidant-antioxidant-status-and-lipid.php $y plný text volně přístupný
910    __
$a ABA008 $b A 3 $c 1073 $y p $z 0
990    __
$a 20230307 $b ABA008
991    __
$a 20230401231519 $b ABA008
999    __
$a ok $b bmc $g 1907472 $s 1187140
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2023 $b 92 $c 1 $d 14-21 $e 20230303 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
LZP    __
$c NLK189 $d 20230401 $b NLK111 $a Actavia-MED00011116-20230307

Najít záznam

Citační ukazatele

Možnosti archivace